— Published date: 6/2/2026
Value Proposition: First-in-class antisense oligonucleotide (ASO) therapy selectively lowering ACOX1 to enable disease-modifying treatment of Mitchell Syndrome and unlocking a metabolic shift facilitating weight loss.
Technology Description: Mitchell Syndrome is an u…
— Published date: 5/23/2026
Value Proposition: Steroidal trifluoromethyl ketone modulators of GABA-A and NMDA receptors for treating migraine, headache, and pain.
Technology Description
Clinical and scientific experts in modulating GABA-A and NMDA receptors at Washington University in St. Louis…
— Value Proposition: This invention uses a novel gene therapy that blocks the axon degeneration typical of neurodegenerative diseases.
Technology Description
Researchers at Washington University in St. Louis have developed a new strategy for treatment of neurodegenerative diseases with axonopathy.…
— Published date: 3/3/2026
Value Proposition: Non-invasive platform that can increase cognitive function in humans.
Technology Description
Researchers at Washington University in St. Louis have developed a system that enables near- real-time control of human brain activity using non-invasive tr…
— Published date: 3/3/2026
Value Proposition: Novel Imaging algorithm process that uses a deep learning neural network prediction model for diagnosing cerebral edema in post-stroke patients.
Technology Description
Researchers at Washington University in St. Louis have developed a novel set of a…
| Name | # Summaries | Author | Action |
|---|---|---|---|
| 15 | |||
| 13 | |||
| 1 | |||
| 15 | |||
| 26 | |||
| 14 | |||
| 14 |
Creating...
